Takaisin Tulosta

Aikuisten kotisyntyinen bakteerikeuhkokuume, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
17.1.2024

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Aikuisten kotisyntyinen bakteerikeuhkokuume «Aikuisten kotisyntyinen bakteerikeuhkokuume»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Ailani RK, Agastya G, Ailani RK, ym. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia. Arch Intern Med 1999;159(3):266-70 «PMID: 9989538»PubMed
  2. Albaum MN, Hill LC, Murphy M, ym. Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators. Chest 1996;110(2):343-50 «PMID: 8697831»PubMed
  3. Biermann C, Løken A, Riise R. Comparison of spiramycin and doxycycline in the treatment of lower respiratory infections in general practice. J Antimicrob Chemother 1988;22 Suppl B():155-8 «PMID: 3053569»PubMed
  4. Blasi F, Garau J, Medina J ym. Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respir Res 2013;14:44
  5. Bohte R, van't Wout JW, Lobatto S, ym. Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 1995;14(3):182-7 «PMID: 7614957»PubMed
  6. Brambilla C, Kastanakis S, Knight S, ym. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections. Eur J Clin Microbiol Infect Dis 1992;11(2):118-24 «PMID: 1396725»PubMed
  7. Brewin A, Arango L, Hadley WK, ym. High-dose penicillin therapy and pneumococcal pneumonia. JAMA 1974;230(3):409-13 «PMID: 4153372»PubMed
  8. British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 2001;56 Suppl 4(Suppl 4):IV1-64
  9. Brixey AG, Luo Y, Skouras V ym. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011;16:1000-4
  10. Cao B, Ren LL, Zhao F, ym. Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. Eur J Clin Microbiol Infect Dis 2010;29(11):1443-8 «PMID: 20623362»PubMed
  11. Carbon C, Ariza H, Rabie WJ ym. Comparative study of levofloxacin and amoxycillin/clavulanic acid in adults with mild-to-moderate community-acquired pneumonia. Clinical Microbiology and Infection 1999;5:724-32C
  12. Chalmers JD, Singanayagam A, Murray MP, ym. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax 2009;64(7):592-7 «PMID: 19131449»PubMed
  13. Claessens YE, Debray MP, Tubach F, ym. Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia. Am J Respir Crit Care Med 2015;192(8):974-82 «PMID: 26168322»PubMed
  14. Dale AP, Marchello C, Ebell MH. Clinical gestalt to diagnose pneumonia, sinusitis, and pharyngitis: a meta-analysis. Br J Gen Pract 2019;69(684):e444-e453 «PMID: 31208974»PubMed
  15. Díaz A, Barria P, Niederman M, ym. Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest 2007;131(3):779-787 «PMID: 17356093»PubMed
  16. Dinh A, Ropers J, Duran C, ym. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet 2021;397(10280):1195-1203 «PMID: 33773631»PubMed
  17. Dwyer R, Hedlund J, Henriques-Normark B, ym. Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia. BMJ Open Respir Res 2014;1(1):e000038 «PMID: 25478185»PubMed
  18. Ebell MH, Bentivegna M, Cai X, ym. Accuracy of Biomarkers for the Diagnosis of Adult Community-acquired Pneumonia: A Meta-analysis. Acad Emerg Med 2020;27(3):195-206 «PMID: 32100377»PubMed
  19. Ebell MH, Chupp H, Cai X, ym. Accuracy of Signs and Symptoms for the Diagnosis of Community-acquired Pneumonia: A Meta-analysis. Acad Emerg Med 2020;27(7):541-553 «PMID: 32329557»PubMed
  20. el Moussaoui R, de Borgie CA, van den Broek P, ym. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006;332(7554):1355 «PMID: 16763247»PubMed
  21. Eliakim-Raz N, Robenshtok E, Shefet D, ym. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2012;2012(9):CD004418 «PMID: 22972070»PubMed
  22. Emamian SA, Kaasbol MA, Olsen JF, ym. Accuracy of the diagnosis of pleural effusion on supine chest X-ray. Eur Radiol 1997;7(1):57-60 «PMID: 9000398»PubMed
  23. Esayag Y, Nikitin I, Bar-Ziv J, ym. Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am J Med 2010;123(1):88.e1-5 «PMID: 20102999»PubMed
  24. File TM Jr, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am 1998;12(3):569-92, vii «PMID: 9779379»PubMed
  25. Finch R, Schürmann D, Collins O, ym. Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. Antimicrob Agents Chemother 2002;46(6):1746-54 «PMID: 12019085»PubMed
  26. Fogarty C, Siami G, Kohler R ym. Multicenter, open-label, randomized study to compare the safety and efficacy of levofloxacin versus ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin-clavulanate in the treatment of serious community-acquired pneumonia in adults. Clin Infect Dis 2004;38(Suppl 1):S16-S23
  27. Frank E, Liu J, Kinasewitz G, ym. A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. Clin Ther 2002;24(8):1292-308 «PMID: 12240780»PubMed
  28. Gleason PP, Meehan TP, Fine JM, ym. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999;159(21):2562-72 «PMID: 10573046»PubMed
  29. Gotfried MH, Dattani D, Riffer E, ym. A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia. Clin Ther 2002;24(5):736-51 «PMID: 12075942»PubMed
  30. Hagberg L, Torres A, van Rensburg D, ym. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia. Infection 2002;30(6):378-86 «PMID: 12478329»PubMed
  31. Harazim H, Wimmer J, Mittermayer HP. An open randomised comparison of ofloxacin and doxycycline in lower respiratory tract infections. Drugs 1987;34 Suppl 1():71-3 «PMID: 3481331»PubMed
  32. Hoeffken G, Meyer HP, Winter J, ym. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. Respir Med 2001;95(7):553-64 «PMID: 11453311»PubMed
  33. Hopstaken RM, Nelemans P, Stobberingh EE, ym. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial. J Fam Pract 2002;51(4):329-36 «PMID: 11978255»PubMed
  34. Hopstaken RM, Witbraad T, van Engelshoven JM, ym. Inter-observer variation in the interpretation of chest radiographs for pneumonia in community-acquired lower respiratory tract infections. Clin Radiol 2004;59(8):743-52 «PMID: 15262550»PubMed
  35. Jokinen C, Heiskanen L, Juvonen H, ym. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis 2001;32(8):1141-54 «PMID: 11283803»PubMed
  36. Katz E, Larsen LS, Fogarty CM, ym. Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy. J Emerg Med 2004;27(4):395-405 «PMID: 15498622»PubMed
  37. Kauppinen MT, Saikku P, Kujala P, ym. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996;51(2):185-9 «PMID: 8711653»PubMed
  38. Kitazono MT, Lau CT, Parada AN, ym. Differentiation of pleural effusions from parenchymal opacities: accuracy of bedside chest radiography. AJR Am J Roentgenol 2010;194(2):407-12 «PMID: 20093603»PubMed
  39. Kolditz M, Ewig S, Schütte H, ym. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. J Intern Med 2015;278(2):193-202 «PMID: 25597400»PubMed
  40. Kuzman I, Daković-Rode O, Oremus M, ym. Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study. J Chemother 2005;17(6):636-42 «PMID: 16433194»PubMed
  41. Lefcoe MS, Fox GA, Leasa DJ, ym. Accuracy of portable chest radiography in the critical care setting. Diagnosis of pneumonia based on quantitative cultures obtained from protected brush catheter. Chest 1994;105(3):885-7 «PMID: 8131557»PubMed
  42. Light RW, Girard WM, Jenkinson SG, ym. Parapneumonic effusions. Am J Med 1980;69(4):507-12 «PMID: 7424940»PubMed
  43. Lim WS, van der Eerden MM, Laing R, ym. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58(5):377-82 «PMID: 12728155»PubMed
  44. López-Alcalde J, Rodriguez-Barrientos R, Redondo-Sánchez J, ym. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database Syst Rev 2018;9(9):CD009070 «PMID: 30188565»PubMed
  45. Maimon N, Nopmaneejumruslers C, Marras TK. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Eur Respir J 2008;31(5):1068-76 «PMID: 18216053»PubMed
  46. Mandell LA, Wunderink RG, Anzueto A, ym. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 Suppl 2(Suppl 2):S27-72 «PMID: 17278083»PubMed
  47. Marchello CS, Ebell MH, Dale AP, ym. Signs and Symptoms That Rule out Community-Acquired Pneumonia in Outpatient Adults: A Systematic Review and Meta-Analysis. J Am Board Fam Med 2019;32(2):234-247 «PMID: 30850460»PubMed
  48. Martinez FJ. Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Clin Infect Dis 2004;38 Suppl 4():S328-40 «PMID: 15127366»PubMed
  49. Metlay JP, Waterer GW, Long AC, ym. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200(7):e45-e67 «PMID: 31573350»PubMed
  50. Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005;330(7489):456 «PMID: 15684024»PubMed
  51. Minnaard MC, de Groot JAH, Hopstaken RM, ym. The added value of C-reactive protein measurement in diagnosing pneumonia in primary care: a meta-analysis of individual patient data. CMAJ 2017;189(2):E56-E63 «PMID: 27647618»PubMed
  52. Miyashita N, Obase Y, Ouchi K, ym. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 2007;56(Pt 12):1625-1629 «PMID: 18033831»PubMed
  53. Mortensen EM, Copeland LA, Pugh MJ ym. Diagnosis of pulmonary malignancy after hospitalization for pneumonia. Am J Med 2010;123:66-71
  54. Norrby SR, Petermann W, Willcox PA, ym. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scand J Infect Dis 1998;30(4):397-404 «PMID: 9817522»PubMed
  55. O'Doherty B, Dutchman DA, Pettit R, ym. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. J Antimicrob Chemother 1997;40 Suppl A():73-81 «PMID: 9484876»PubMed
  56. Pakhale S, Mulpuru S, Verheij TJ, ym. Antibiotics for community-acquired pneumonia in adult outpatients. Cochrane Database Syst Rev 2014;2014(10):CD002109 «PMID: 25300166»PubMed
  57. Panizo-Alcañiz J, Frutos-Vivar F, Thille AW, ym. Diagnostic accuracy of portable chest radiograph in mechanically ventilated patients when compared with autopsy findings. J Crit Care 2020;60():6-9 «PMID: 32731104»PubMed
  58. Pauls S, Krüger S, Richter K, ym. [Interobserver agreement in the assessment of pulmonary infiltrates on chest radiography in community-acquired pneumonia]. Rofo 2007;179(11):1152-8 «PMID: 17948193»PubMed
  59. Petitpretz P, Arvis P, Marel M, ym. Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults. Chest 2001;119(1):185-95 «PMID: 11157603»PubMed
  60. Plouffe J, Schwartz DB, Kolokathis A, ym. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group. Antimicrob Agents Chemother 2000;44(7):1796-802 «PMID: 10858333»PubMed
  61. Prendki V, Scheffler M, Huttner B, ym. Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study. Eur Respir J 2018;51(5): «PMID: 29650558»PubMed
  62. Ragnar Norrby S. Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group. J Antimicrob Chemother 1997;39(4):499-508 «PMID: 9145823»PubMed
  63. Rello J, Bodi M, Mariscal D ym. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2003;123:174-80
  64. Rosón B, Carratalà J, Fernández-Sabé N, ym. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 2004;164(5):502-8 «PMID: 15006826»PubMed
  65. Ruiz M, Ewig S, Torres A, ym. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 1999;160(3):923-9 «PMID: 10471620»PubMed
  66. Said MA, Johnson HL, Nonyane BA, ym. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One 2013;8(4):e60273 «PMID: 23565216»PubMed
  67. Shariatzadeh M, Marrie TJ. Reasons for coming to hospital after treatment for community-acquired pneumonia on an ambulatory basis. Can Respir J 2006;13(3):139-43 «PMID: 16642228»PubMed
  68. Shefet D, Robenshtok E, Paul M, ym. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005;165(17):1992-2000 «PMID: 16186469»PubMed
  69. Shepshelovich D, Barda N, Goldvaser H, ym. Incidence of lung cancer following pneumonia in smokers: a population-based study. QJM 2022;115(5):287-291 «PMID: 33576784»PubMed
  70. Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan) 2020;12():11 «PMID: 33024653»PubMed
  71. Sicras-Mainar A, Ibáñez-Nolla J, Cifuentes I ym. Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain). BMC Infect Dis 2012;12:283
  72. Smith SM, Fahey T, Smucny J, ym. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2017;6(6):CD000245 «PMID: 28626858»PubMed
  73. Syrjälä H, Broas M, Suramo I, ym. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 1998;27(2):358-63 «PMID: 9709887»PubMed
  74. Søgaard KK, Farkas DK, Pedersen L, ym. Pneumonia and the incidence of cancer: a Danish nationwide cohort study. J Intern Med 2015;277(4):429-38 «PMID: 24831031»PubMed
  75. Tang KL, Eurich DT, Minhas-Sandhu JK, ym. Incidence, correlates, and chest radiographic yield of new lung cancer diagnosis in 3398 patients with pneumonia. Arch Intern Med 2011;171(13):1193-8 «PMID: 21518934»PubMed
  76. Tansarli GS, Mylonakis E. Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults. Antimicrob Agents Chemother 2018;62(9): «PMID: 29987137»PubMed
  77. Torres A, Muir JF, Corris P ym. Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia. Eur Respir J 2003;21:135-43
  78. Trémolières F, de Kock F, Pluck N, ym. Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis 1998;17(6):447-53 «PMID: 9758291»PubMed
  79. Vergis EN, Indorf A, File TM Jr, ym. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med 2000;160(9):1294-300 «PMID: 10809032»PubMed
  80. von Baum H, Welte T, Marre R ym. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis 2009;9:62
  81. Welte T, Petermann W, Schürmann D, ym. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Clin Infect Dis 2005;41(12):1697-705 «PMID: 16288390»PubMed
  82. Woodhead M, Blasi F, Ewig S ym. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect 2011;17(Suppl 6):E1-59
Artikkelin tunnus: nix03343 (050.100)
© 2024 Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit